- Report
- July 2024
- 300 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- February 2025
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 204 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- January 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- April 2024
- 140 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- March 2023
- 254 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- August 2022
- 46 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- November 2023
- 200 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2022
- 82 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- June 2023
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- May 2023
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 318 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- October 2024
- 103 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Book
- June 2024
- 496 Pages

The Randomization Trial Supply Management (RTSM) market is a specialized segment of the clinical trial industry. It focuses on the management of supplies used in clinical trials, such as drugs, medical devices, and other materials. RTSM services include the management of inventory, distribution, and tracking of supplies. This helps to ensure that clinical trials are conducted in a safe and efficient manner.
RTSM services are provided by a variety of companies, including clinical research organizations (CROs), contract research organizations (CROs), and technology providers. These companies provide services such as supply chain management, inventory management, and distribution services. They also provide software solutions to help manage the supply chain and ensure that clinical trials are conducted in a timely and cost-effective manner.
Some of the companies in the RTSM market include Parexel, ICON, Covance, PPD, and Syneos Health. Show Less Read more